Vaishali Pharma Limited has confirmed that their shares are fully in demat form and no requests for rematerialization were received for the quarter ended 31st March, 2025, as per SEBI regulations.
AI Assistant
Vaishali Pharma Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.